BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 18791205)

  • 1. Bone marrow CXCR4 induction by cultivation enhances therapeutic angiogenesis.
    Shiba Y; Takahashi M; Hata T; Murayama H; Morimoto H; Ise H; Nagasawa T; Ikeda U
    Cardiovasc Res; 2009 Jan; 81(1):169-77. PubMed ID: 18791205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CXCR4 expression determines functional activity of bone marrow-derived mononuclear cells for therapeutic neovascularization in acute ischemia.
    Seeger FH; Rasper T; Koyanagi M; Fox H; Zeiher AM; Dimmeler S
    Arterioscler Thromb Vasc Biol; 2009 Nov; 29(11):1802-9. PubMed ID: 19696399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene transfer of stromal cell-derived factor-1alpha enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor/endothelial nitric oxide synthase-related pathway: next-generation chemokine therapy for therapeutic neovascularization.
    Hiasa K; Ishibashi M; Ohtani K; Inoue S; Zhao Q; Kitamoto S; Sata M; Ichiki T; Takeshita A; Egashira K
    Circulation; 2004 May; 109(20):2454-61. PubMed ID: 15148275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stromal cell-derived factor 1/CXCR4 signaling is critical for the recruitment of mesenchymal stem cells to the fracture site during skeletal repair in a mouse model.
    Kitaori T; Ito H; Schwarz EM; Tsutsumi R; Yoshitomi H; Oishi S; Nakano M; Fujii N; Nagasawa T; Nakamura T
    Arthritis Rheum; 2009 Mar; 60(3):813-23. PubMed ID: 19248097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of fractalkine/CX3CR1 by vascular endothelial cells induces angiogenesis through VEGF-A/KDR and reverses hindlimb ischaemia.
    Ryu J; Lee CW; Hong KH; Shin JA; Lim SH; Park CS; Shim J; Nam KB; Choi KJ; Kim YH; Han KH
    Cardiovasc Res; 2008 May; 78(2):333-40. PubMed ID: 18006432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of systemic administration of SDF-1 in a model of vascular insufficiency: support for an endothelium-dependent mechanism.
    Carr AN; Howard BW; Yang HT; Eby-Wilkens E; Loos P; Varbanov A; Qu A; DeMuth JP; Davis MG; Proia A; Terjung RL; Peters KG
    Cardiovasc Res; 2006 Mar; 69(4):925-35. PubMed ID: 16409996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased expression of CXCR4 and integrin alphaM in hypoxia-preconditioned cells contributes to improved cell retention and angiogenic potency.
    Kubo M; Li TS; Kamota T; Ohshima M; Qin SL; Hamano K
    J Cell Physiol; 2009 Aug; 220(2):508-14. PubMed ID: 19415696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease.
    Heeschen C; Lehmann R; Honold J; Assmus B; Aicher A; Walter DH; Martin H; Zeiher AM; Dimmeler S
    Circulation; 2004 Apr; 109(13):1615-22. PubMed ID: 15037527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caveolin plays a central role in endothelial progenitor cell mobilization and homing in SDF-1-driven postischemic vasculogenesis.
    Sbaa E; Dewever J; Martinive P; Bouzin C; Frérart F; Balligand JL; Dessy C; Feron O
    Circ Res; 2006 May; 98(9):1219-27. PubMed ID: 16601228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of the stromal cell-derived factor-1/CXCR4 axis attenuates in vivo tumor growth by inhibiting angiogenesis in a vascular endothelial growth factor-independent manner.
    Guleng B; Tateishi K; Ohta M; Kanai F; Jazag A; Ijichi H; Tanaka Y; Washida M; Morikane K; Fukushima Y; Yamori T; Tsuruo T; Kawabe T; Miyagishi M; Taira K; Sata M; Omata M
    Cancer Res; 2005 Jul; 65(13):5864-71. PubMed ID: 15994964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone marrow stromal cells and the upregulation of interleukin-8 production in human T-cell acute lymphoblastic leukemia through the CXCL12/CXCR4 axis and the NF-kappaB and JNK/AP-1 pathways.
    Scupoli MT; Donadelli M; Cioffi F; Rossi M; Perbellini O; Malpeli G; Corbioli S; Vinante F; Krampera M; Palmieri M; Scarpa A; Ariola C; Foà R; Pizzolo G
    Haematologica; 2008 Apr; 93(4):524-32. PubMed ID: 18322253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of chemokine stromal cell derived factor-1 and its receptor CXCR4 on the peritoneal carcinometastasis of gastric cancer].
    Ding YL; Zhang JL; Tang SF; Fu QY; Li ZT
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(3):202-5. PubMed ID: 18361822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sphingosine-1-phosphate stimulates the functional capacity of progenitor cells by activation of the CXCR4-dependent signaling pathway via the S1P3 receptor.
    Walter DH; Rochwalsky U; Reinhold J; Seeger F; Aicher A; Urbich C; Spyridopoulos I; Chun J; Brinkmann V; Keul P; Levkau B; Zeiher AM; Dimmeler S; Haendeler J
    Arterioscler Thromb Vasc Biol; 2007 Feb; 27(2):275-82. PubMed ID: 17158356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular endothelial growth factor-C derived from CD11b+ cells induces therapeutic improvements in a murine model of hind limb ischemia.
    Kuwahara G; Nishinakamura H; Kojima D; Tashiro T; Kodama S
    J Vasc Surg; 2013 Apr; 57(4):1090-9. PubMed ID: 23219511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ex vivo priming of endothelial progenitor cells with SDF-1 before transplantation could increase their proangiogenic potential.
    Zemani F; Silvestre JS; Fauvel-Lafeve F; Bruel A; Vilar J; Bieche I; Laurendeau I; Galy-Fauroux I; Fischer AM; Boisson-Vidal C
    Arterioscler Thromb Vasc Biol; 2008 Apr; 28(4):644-50. PubMed ID: 18239152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating bone marrow-derived osteoblast progenitor cells are recruited to the bone-forming site by the CXCR4/stromal cell-derived factor-1 pathway.
    Otsuru S; Tamai K; Yamazaki T; Yoshikawa H; Kaneda Y
    Stem Cells; 2008 Jan; 26(1):223-34. PubMed ID: 17932420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stromal cell-derived factor-1alpha-directed chemoattraction of transiently CXCR4-overexpressing bone marrow stromal cells into functionalized three-dimensional biomimetic scaffolds.
    Thieme S; Ryser M; Gentsch M; Navratiel K; Brenner S; Stiehler M; Rölfing J; Gelinsky M; Rösen-Wolff A
    Tissue Eng Part C Methods; 2009 Dec; 15(4):687-96. PubMed ID: 19260802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired angiogenesis after hindlimb ischemia in type 2 diabetes mellitus: differential regulation of vascular endothelial growth factor receptor 1 and soluble vascular endothelial growth factor receptor 1.
    Hazarika S; Dokun AO; Li Y; Popel AS; Kontos CD; Annex BH
    Circ Res; 2007 Oct; 101(9):948-56. PubMed ID: 17823371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The induction of angiogenesis by the implantation of autologous bone marrow cells: a novel and simple therapeutic method.
    Hamano K; Li TS; Kobayashi T; Tanaka N; Kobayashi S; Matsuzaki M; Esato K
    Surgery; 2001 Jul; 130(1):44-54. PubMed ID: 11436011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implantation of adipose-derived regenerative cells enhances ischemia-induced angiogenesis.
    Kondo K; Shintani S; Shibata R; Murakami H; Murakami R; Imaizumi M; Kitagawa Y; Murohara T
    Arterioscler Thromb Vasc Biol; 2009 Jan; 29(1):61-6. PubMed ID: 18974384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.